Javascript must be enabled to continue!
Evaluation of a new hyperbaric oxygen ventilator during pressure-controlled ventilation
View through CrossRef
Introduction: The stability of a new hyperbaric ventilator (Shangrila590, Beijing Aeonmed Company, Beijing, China) at different clinically relevant pressures in a hyperbaric chamber during pressure-controlled ventilation (PCV) was investigated. Methods: The ventilator was connected to a test lung in the multiplace hyperbaric chamber. The inspiratory pressure (PI) of the ventilator was set to 1.0, 1.5, 2.0, 2.5 and 3.0 kPa (approximately 10, 15, 20, 25 and 30 cmH₂O). The compliance and resistance of the test lung were set to 200 mL·kPa⁻¹ and 2 kPa·L⁻¹·s⁻¹, respectively. Experiments were conducted at 101, 203 and 284 kPa ambient pressure (1.0, 2.0 and 2.8 atmospheres absolute respectively). At each of the 5 PI values, the tidal volume (VT), peak inspiratory pressure (Ppeak) and peak inspiratory flow (Fpeak) displayed by the ventilator and the test lung were recorded for 20 cycles. Test lung data were considered the actual ventilation values. The ventilation data were compared among the three groups to evaluate the stability of the ventilator. Results: At every PI, the Ppeak detected by the ventilator decreased slightly with increasing ambient pressure. The Fpeak values measured by the test lung decreased substantially as the ambient pressure increased. Nevertheless, the reduction in VT at 284 kPa and PI 30 cmH₂O (compared to performance at 101 kPa) was comparatively small (approximately 60 ml). Conclusions: In PCV mode this ventilator provided relatively stable VT across clinically relevant PI values to ambient pressures as high as 284 kPa. However, because Fpeak decreases at higher ambient pressure, some user adjustment might be necessary for precise VT maintenance during clinical use at higher PIs and ambient pressures.
Diving and Hyperbaric Medicine Journal
Title: Evaluation of a new hyperbaric oxygen ventilator during pressure-controlled ventilation
Description:
Introduction: The stability of a new hyperbaric ventilator (Shangrila590, Beijing Aeonmed Company, Beijing, China) at different clinically relevant pressures in a hyperbaric chamber during pressure-controlled ventilation (PCV) was investigated.
Methods: The ventilator was connected to a test lung in the multiplace hyperbaric chamber.
The inspiratory pressure (PI) of the ventilator was set to 1.
0, 1.
5, 2.
0, 2.
5 and 3.
0 kPa (approximately 10, 15, 20, 25 and 30 cmH₂O).
The compliance and resistance of the test lung were set to 200 mL·kPa⁻¹ and 2 kPa·L⁻¹·s⁻¹, respectively.
Experiments were conducted at 101, 203 and 284 kPa ambient pressure (1.
0, 2.
0 and 2.
8 atmospheres absolute respectively).
At each of the 5 PI values, the tidal volume (VT), peak inspiratory pressure (Ppeak) and peak inspiratory flow (Fpeak) displayed by the ventilator and the test lung were recorded for 20 cycles.
Test lung data were considered the actual ventilation values.
The ventilation data were compared among the three groups to evaluate the stability of the ventilator.
Results: At every PI, the Ppeak detected by the ventilator decreased slightly with increasing ambient pressure.
The Fpeak values measured by the test lung decreased substantially as the ambient pressure increased.
Nevertheless, the reduction in VT at 284 kPa and PI 30 cmH₂O (compared to performance at 101 kPa) was comparatively small (approximately 60 ml).
Conclusions: In PCV mode this ventilator provided relatively stable VT across clinically relevant PI values to ambient pressures as high as 284 kPa.
However, because Fpeak decreases at higher ambient pressure, some user adjustment might be necessary for precise VT maintenance during clinical use at higher PIs and ambient pressures.
Related Results
Performance of the Oxylog® 1000 portable ventilator in a hyperbaric environment
Performance of the Oxylog® 1000 portable ventilator in a hyperbaric environment
Introduction: The management of mechanically ventilated patients in the hyperbaric environment requires knowledge of how the physical properties of gases change under pressure and ...
Adaptive split ventilator system enables parallel ventilation, individual monitoring and ventilation pressures control for each lung simulators
Adaptive split ventilator system enables parallel ventilation, individual monitoring and ventilation pressures control for each lung simulators
Abstract
Objective
In mass crisis setting such as the COVID-19 pandemic, the number of patients requiring ...
N-terminal pro-B-type natriuretic peptide levels increases after hyperbaric oxygen therapy in diabetic patients
N-terminal pro-B-type natriuretic peptide levels increases after hyperbaric oxygen therapy in diabetic patients
Purpose Diabetic patients receive hyperbaric oxygen therapy for non-healing lower extremity ulcers. Exposure to hyperbaric hyperoxia during hyperbaric oxygen therapy may affect car...
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Objective: Given the high mortality and prolonged duration of mechanical ventilation of COVID-19 patients, we evaluated the safety and efficacy of hyperbaric oxygen for COVID-19 pa...
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Objective: Given the high mortality and prolonged duration of mechanical ventilation of COVID-19 patients, we evaluated the safety and efficacy of hyperbaric oxygen for COVID-19 pa...
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls
Objective: Given the high mortality and prolonged duration of mechanical ventilation of COVID-19 patients, we evaluated the safety and efficacy of hyperbaric oxygen for COVID-19 pa...
Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens
Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens
Leder Macek AJ, Wang RS, Cottrell J, Kay-Rivest E, McMenomey SO, Roland Jr. T, Ross FL. Hyperbaric Oxygen Therapy for Sudden Sensorineural Hearing Loss – A Comorbidity Lens. Unders...
Critical care nurses' knowledge and attitudes toward using ventilator waveform monitoring to detect patient-ventilator asynchrony: A cross-sectional online survey
Critical care nurses' knowledge and attitudes toward using ventilator waveform monitoring to detect patient-ventilator asynchrony: A cross-sectional online survey
Abstract
Background
Most mechanically ventilated patients will be exposed to some asynchrony with the ventilator. Inability to detect and manage patient-ventilator asynchr...

